Zhenwei Han

749 total citations
33 papers, 481 citations indexed

About

Zhenwei Han is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhenwei Han has authored 33 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 12 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhenwei Han's work include RNA modifications and cancer (6 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (5 papers). Zhenwei Han is often cited by papers focused on RNA modifications and cancer (6 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (5 papers). Zhenwei Han collaborates with scholars based in China, United States and Australia. Zhenwei Han's co-authors include Yaxuan Wang, Shuyuan Yeh, Jingdong Li, Yanping Zhang, Xiaolu Wang, Jingdong Li, Chawnshang Chang, Ronghao Wang, Cuntai Zhang and Yin Sun and has published in prestigious journals such as Cancer Research, Oncogene and Scientific Reports.

In The Last Decade

Zhenwei Han

29 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenwei Han China 12 305 216 131 80 53 33 481
Nino Sinčić Croatia 13 384 1.3× 155 0.7× 95 0.7× 143 1.8× 26 0.5× 53 582
Yangle Li China 13 214 0.7× 165 0.8× 82 0.6× 117 1.5× 14 0.3× 30 384
Bogdan Petruţ Romania 11 255 0.8× 230 1.1× 106 0.8× 80 1.0× 14 0.3× 41 431
Hai Cai China 14 163 0.5× 94 0.4× 191 1.5× 59 0.7× 13 0.2× 34 408
Chengqiang Mo China 12 286 0.9× 191 0.9× 131 1.0× 129 1.6× 9 0.2× 29 511
Samornmas Kanngurn Thailand 11 239 0.8× 101 0.5× 74 0.6× 80 1.0× 23 0.4× 25 442
Wenbin Yu China 15 264 0.9× 183 0.8× 154 1.2× 161 2.0× 97 1.8× 59 584
P.V. Newcomb United Kingdom 12 243 0.8× 133 0.6× 126 1.0× 167 2.1× 195 3.7× 14 538
Tomoya Fukawa Japan 11 164 0.5× 60 0.3× 104 0.8× 116 1.4× 17 0.3× 62 392
Paulo Príncipe Portugal 9 156 0.5× 193 0.9× 192 1.5× 31 0.4× 12 0.2× 12 438

Countries citing papers authored by Zhenwei Han

Since Specialization
Citations

This map shows the geographic impact of Zhenwei Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenwei Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenwei Han more than expected).

Fields of papers citing papers by Zhenwei Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenwei Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenwei Han. The network helps show where Zhenwei Han may publish in the future.

Co-authorship network of co-authors of Zhenwei Han

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenwei Han. A scholar is included among the top collaborators of Zhenwei Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenwei Han. Zhenwei Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yaxuan, et al.. (2025). AL161431.1 is identified as a biomarker for bladder cancer progression and immunotherapy response. Scientific Reports. 15(1). 1170–1170.
2.
Tang, Peng, Zhenwei Han, Tianxin Xu, et al.. (2025). ALG3 as a prognostic biomarker and mediator of PD-1 blockade resistance in hepatocellular carcinoma. Frontiers in Immunology. 16. 1589153–1589153. 1 indexed citations
3.
Ni, Qingfeng, Yuanjie Niu, Zhenwei Han, et al.. (2025). Single-cell transcriptomic data reveal the cellular heterogeneity of glutamine metabolism in gastric premalignant lesions and early gastric cancer. Acta Biochimica et Biophysica Sinica. 57(10). 1670–1683.
4.
Li, Zhichao, et al.. (2024). Genetically predicted asthma and the risk of abnormal spermatozoa. Frontiers in Genetics. 15. 1377770–1377770.
5.
Yang, Zhan, Yaxuan Wang, Jin‐Kun Wen, et al.. (2023). SF3B4 promotes Twist1 expression and clear cell renal cell carcinoma progression by facilitating the export of KLF 16 mRNA from the nucleus to the cytoplasm. Cell Death and Disease. 14(1). 26–26. 15 indexed citations
6.
Wang, Hu, Zhan Yang, Xingyu He, et al.. (2023). Cuproptosis related gene PDHB is identified as a biomarker inversely associated with the progression of clear cell renal cell carcinoma. BMC Cancer. 23(1). 804–804. 15 indexed citations
7.
Sun, Hao, Zhan Yang, Yanping Zhang, et al.. (2023). DDX58 expression promotes inflammation and growth arrest in Sertoli cells by stabilizing p65 mRNA in patients with Sertoli cell-only syndrome. Frontiers in Immunology. 14. 4 indexed citations
8.
10.
Han, Zhenwei, et al.. (2021). Efficacy and safety of laparoendoscopic single-site adrenalectomy versus conventional laparoscopic adrenalectomy: an updated systematic review and meta-analysis.. Videosurgery and Other Miniinvasive Techniques. 17(1). 20–34. 5 indexed citations
11.
Wang, Yaxuan, et al.. (2021). Prestenting Versus Nonprestenting on the Outcomes of Flexible Ureteroscopy for Large Upper Urinary Stones: A Systematic Review and Meta-Analysis. Urologia Internationalis. 105(7-8). 560–567. 13 indexed citations
12.
Wang, Yaxuan, et al.. (2021). Right laparoscopic adrenalectomy vs. left laparoscopic adrenalectomy: a systematic review and meta-analysis.. Videosurgery and Other Miniinvasive Techniques. 17(1). 9–19. 6 indexed citations
13.
Li, Jingdong, et al.. (2020). Laparoscopic ureterolithotomy versus ureteroscopic laser lithotripsy for large proximal ureteral stones: a systematic review and meta-analysis. Minerva Urologica e Nefrologica. 72(1). 30–37. 9 indexed citations
14.
Li, Jingdong, et al.. (2020). Laparoscopic adrenalectomy (LA) vs open adrenalectomy (OA) for pheochromocytoma (PHEO): A systematic review and meta-analysis. European Journal of Surgical Oncology. 46(6). 991–998. 43 indexed citations
15.
Gu, Junfei, Yong Zhang, Zhenwei Han, et al.. (2020). Targeting the ERβ/Angiopoietin-2/Tie-2 signaling-mediated angiogenesis with the FDA-approved anti-estrogen Faslodex to increase the Sunitinib sensitivity in RCC. Cell Death and Disease. 11(5). 367–367. 24 indexed citations
16.
Gao, Lei, Jialin Meng, Yong Zhang, et al.. (2020). Development and validation of a six-RNA binding proteins prognostic signature and candidate drugs for prostate cancer. Genomics. 112(6). 4980–4992. 16 indexed citations
17.
Li, Jingdong, et al.. (2019). Partial nephrectomy versus radical nephrectomy for cT2 or greater renal tumors: a systematic review and meta-analysis. Minerva Urologica e Nefrologica. 71(5). 435–444. 26 indexed citations
18.
Zhang, Yanping, Kailong Liu, Yaxuan Wang, et al.. (2019). Down‐regulated RBM5 inhibits bladder cancer cell apoptosis by initiating an miR‐432‐5p/β‐catenin feedback loop. The FASEB Journal. 33(10). 10973–10985. 26 indexed citations
19.
Han, Zhenwei, Yong Zhang, Yin Sun, et al.. (2018). ERβ-Mediated Alteration of circATP2B1 and miR-204-3p Signaling Promotes Invasion of Clear Cell Renal Cell Carcinoma. Cancer Research. 78(10). 2550–2563. 65 indexed citations
20.
Yu, Weiwei, Jie Ding, Yuan Chen, et al.. (2018). Estrogen receptor β promotes the vasculogenic mimicry (VM) and cell invasion via altering the lncRNA-MALAT1/miR-145-5p/NEDD9 signals in lung cancer. Oncogene. 38(8). 1225–1238. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026